logo

For the Inventor, By the Inventor

West Chester, OH, United States of America

Mitchell Anthony DeLong

This inventor holds 16 USPTO granted patents. Top assignees: The Procter Gamble Company, Duke University, Cincinnati Children's Hospital Medical Center. Active years: 2000-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitchell Anthony DeLong. Retrieved from https://idiyas.com/inventor/mitchell-anthony-delong-qc85k4ku

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 81.3

Average Co-Inventor Count = 2.6

ph-index = 11

Forward Citations = 311(Granted Patents)


Location History:

  • West Chester, OH (US) (2000 - 2008)
  • Raleigh, NC (US) (2013)

Company Filing History:

goldMedal13 out of 17,173 
 
The Procter Gamble Company
 patents
silverMedal2 out of 2,085 
 
Duke University
 patents
bronzeMedal1 out of 429 
 
Cincinnati Children's Hospital Medical Center
 patents

Years Active: 2000-2013

Loading Chart...
16 patents (USPTO):Explore Patents
1. 8541466 - Compositions and methods for treating hair loss using non-naturally occurring prostaglandins (2013-09-24),
2. 7388029 - Compositions and methods for treating hair loss using non-naturally occurring prostaglandins (2008-06-17),
3. 7115659 - Method of treating a condition by administering a prostaglandin derivative (2006-10-03),
4. 7074942 - 2-decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use (2006-07-11),
5. 6894175 - 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use (2005-05-17),
6. 6586463 - C16 unsaturated FP-selective prostaglandins analogs (2003-07-01),
7. 6537527 - Skin lightening compositions (2003-03-25),
8. 6451859 - C16 unsaturated FP-selective prostaglandins analogs (2002-09-17),
9. 6444840 - C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists (2002-09-03),
10. 6410780 - C11 oxymyl and hydroxylamino prostaglandins useful as medicaments (2002-06-25),
11. 6372730 - 2-decarboxy-2-phosphinico Prostaglandin F analogs (2002-04-16),
12. 6156799 - Method of increasing bone volume using non-naturally-occurring FP (2000-12-05),
13. 6107338 - Aromatic C.sub.16 -C.sub.20 -substituted tetrahydro prostaglandins (2000-08-22),
14. 6068834 - Skin lightening compositions (2000-05-30),
15. 6066751 - Process for making epoxide intermediates (2000-05-23),

Title: The Innovative Contributions of Mitchell Anthony DeLong

Introduction

Mitchell Anthony DeLong is a notable inventor based in West Chester, OH (US). He has made significant contributions to the field of hair loss treatment, holding a total of 16 patents. His work focuses on innovative methods and compositions that address hair loss in mammals.

Latest Patents

Among his latest patents is a groundbreaking method for treating hair loss using non-naturally occurring prostaglandins. This method utilizes compositions containing prostaglandin F analogs, which can be applied topically to the skin. These compositions are designed to arrest hair loss, reverse hair loss, and promote hair growth, showcasing DeLong's commitment to advancing treatment options in this area.

Career Highlights

Throughout his career, DeLong has worked with prominent organizations, including The Procter & Gamble Company and Duke University. His experience in these esteemed institutions has allowed him to refine his research and develop effective solutions for hair loss.

Collaborations

DeLong has collaborated with notable individuals in his field, including John August Wos and Biswanath De. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Mitchell Anthony DeLong's innovative work in the treatment of hair loss has made a significant impact in the field. His numerous patents and collaborations reflect his dedication to improving the lives of those affected by hair loss.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…